Dextranomer/hyaluronic acid has the potential to lower the cost and also the morbidity of repeated voiding cystourethrograms in children.
AUGS Position Statement on Gender Affirmation
The position statement is meant to iterate AUGS' support for gender inclusion of both patients and health care providers.
Dr. Malik evaluates quality of Reddit content on recurrent UTIs
“I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.
AUGS Position Statement: Vaginal Pessary Use and Management for Pelvic Organ Prolapse
The purpose of this clinical consensus statement is to identify areas of expert consensus and nonconsensus regarding pessary fitting, follow-up, and management of pessary complications to improve the safety and quality of care where evidence is currently limited.
Destigmatizing Urology: Dr. Blaivas discusses vaginal mesh surgery
“To me, the overwhelming thing is understanding that treatments are, by and large, effective,” says Jerry G. Blaivas, MD, FACS.
Oral sulopenem shows superiority to amoxicillin/clavulanate for uUTIs
Iterum plans to resubmit a New Drug Application for oral sulopenem for the treatment of patients with uUTi in Q2 of 2024.
Apply for a 2024 AUGS Foundation Grant
The goals of the American Urogynecologic Society (AUGS) program are to support novel clinical, translational, and bench research pilot projects and enable early career investigators to obtain future independent funding for research.
2 Commerce Drive Cranbury, NJ 08512